The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 3,401–3,517 of 3,517
Treatment of antidepressant-induced sexual dysfunction
Worthington, J. J., & Peters, P. (2003) · Drugs of today · doi:10.1358/dot.2003.39.11.799466 · Cited by 17
Citalopram treatment of paroxetine-intolerant depressed patients
Thase, M. E., Ferguson, J. M., Lydiard, R. B., & Wilcox, C. S. (2002) · Depression and Anxiety · doi:10.1002/da.10055 · Cited by 17
Adrenoceptor mechanisms underlying imipramine-induced memory deficits in rats
Zarrindast, M., Ghiasvand, M., Homayoun, H., Rostami, P., Shafaghi, B., & Khavandgar, S. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017001709 · Cited by 17
Effects of Reboxetine on Sleep and Nocturnal Cardiac Autonomic Activity in Patients with Dysthymia
Ferini-Strambi, L., Manconi, M., Castronovo, V., Riva, L., & Bianchi, A. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800313 · Cited by 17
Green, T. D., Reynolds, C. F., Mulsant, B. H., Pollock, B. G., Miller, M. D., Houck, P. R., Mazumdar, S., Dew, M. A., & Kupfer, D. J. (1999) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879901200205 · Cited by 17
Selective effects of simultaneous monoamine depletion on mood and emotional responsiveness
Hughes, J.-M., Matrenza, C., Kemp, A. H., Harrison, B. J., Liley, D., & Nathan, P. J. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003845 · Cited by 16
Marthi, K., Jakobsen, S., Bender, D., Hansen, S., Smith, S., Hermansen, F., Rosenberg, R., & Smith, D. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1754-x · Cited by 16
Effect of clenbuterol on sexual behavior in male rats
Benelli, A., Zanoli, P., & Bertolini, A. (1990) · Physiology & Behavior · doi:10.1016/0031-9384(90)90156-x · Cited by 16
Carbonell, L., Cuffí, M. L., & FORN, J. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.02.001 · Cited by 16
Direct effects of ovarian hormones on antidepressant binding sites
Wilson, M. A., Dwyer, K. D., & Roy, E. J. (1989) · Brain Research Bulletin · doi:10.1016/0361-9230(89)90040-3 · Cited by 16
Cespuglio, R., Rousset, C., Debilly, G., Rochat, C., & Millan, M. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0016-5 · Cited by 16
Self-citationNewman‐Tancredi, A., Verrièle, L., Chaput, C., & Millan, M. J. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(96)00150-5 · Cited by 16
Self-citationÖnder, E. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00090-3 · Cited by 16
Perez, N. M. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)10002-8 · Cited by 16
Nathan, P. J., & Stough, C. K. K. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1484 · Cited by 16
Current and potential pharmacological treatments for obsessive-compulsive disorder
Davidson, J., & Björgvinsson, Þ. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.6.993 · Cited by 16
Methods in Neuroendocrinology.
Bohus, B. G. J. (1998) · Cited by 16
Jm, G. G., & Perramón, C. T. (2000) · PubMed · Cited by 15
Lamotrigine in Psychiatry: Pharmacology and Therapeutics
Jefferson, J. W. (2005) · CNS Spectrums · doi:10.1017/s1092852900010063 · Cited by 15
Moriya, T., Ikeda, M., Teshima, K., Hara, R., Kuriyama, K., Yoshioka, T., Allen, C. N., & Shibata, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01758.x · Cited by 15
Zhu, M., Wang, W.-P., Baldessarini, R. J., & Kim, K. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.10.009 · Cited by 15
Nocturnal prolactin and cortisol secretion and recovery from melancholia
Lisansky, J., Fava, G. A., Zielezny, M. A., Morphy, M. A., & Kellner, R. (1987) · Psychoneuroendocrinology · doi:10.1016/0306-4530(87)90055-2 · Cited by 15
Boldogkői, Z. (2004) · Journal of Molecular Evolution · doi:10.1007/s00239-004-2629-4 · Cited by 15
Dopamine D1 receptor agonists induce penile erections in rats
D’Aquila, P. S., Panin, F., Cossu, M. L., Peana, A. T., & Serra, G. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02881-9 · Cited by 15
Seifritz, E., Müller, M. J., Annen, O., Nil, R., Hatzinger, M., Hemmeter, U., Moore, P., & Holsboer‐Trachsler, E. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00020-4 · Cited by 15
Southmayd, S. E., Kasurak, P. C., Macdonald, B., & Waldron, J. J. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03232.x · Cited by 15
Treatment strategies in achieving remission in major depressive disorder
Kelsey, J. E. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.106.s415.4.x · Cited by 15
Focus on Polypharmacy in schizophrenia: does anyone truly benefit?
GOFF, D. C., & Freudenreich, O. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004183 · Cited by 15
Rogóż, Z., Skuza, G., Wójcikowski, J., & Daniel, W. A. (2003) · PubMed · Cited by 15
Effects of alpha-2 blockade on sexual response: experimental studies with Delequamine (RS15385)
Bancroft, J. (2000) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900507 · Cited by 15
Differential Distribution of GABAB1 and GABAB2 Receptor mRNAs in the Rat Brain
Li, S. P., Park, M. S., Yoon, H., Rhee, K.-H., Bahk, J. Y., Lee, J. H., Park, J. S., & Kim, M. O. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13763-0 · Cited by 15
Daunais, J. B., Hart, S. L., Smith, H. R., Letchworth, S. R., Davies, H. M. L., Sexton, T., Bennett, B. A., Childers, S. R., & Porrino, L. J. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37535-4 · Cited by 15
Wolf, W. A. (2003) · PubMed · Cited by 14
Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase
Millan, M. J., Newman‐Tancredi, A., Duqueyroix, D., & Cussac, D. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01127-x · Cited by 14
Self-citationAntipsychotic drug treatment: recent advances
Barnes, T. R. E., & Joyce, E. M. (2001) · Current Opinion in Psychiatry · doi:10.1097/00001504-200101000-00005 · Cited by 14
Fischer, P. Q., Tauscher, J. T., Kufferle, B., & Kasper, S. F. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199803000-00005 · Cited by 14
Smith, E. R., Kacker, S. R., Raskin, A., Yun, P. T., Davidson, J. M., Hoffman, B. B., & Clark, J. T. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(95)02128-0 · Cited by 14
Chang, A. Y., Huang, C., Chan, J. Y. H., & Chan, S. H. H. (2001) · Hippocampus · doi:10.1002/hipo.1094 · Cited by 14
de Kar, L. D. V. (2020) · CRC Press eBooks · doi:10.1201/9780429333194 · Cited by 14
Jardemark, K. E., Marcus, M. M., Konradsson‐Geuken, Å., & Svensson, T. H. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004742 · Cited by 14
Does mirtazapine enhance serotonergic neurotransmission in depressed patients?
Whale, R., Clifford, E. M., & Cowen, P. J. (2000) · Psychopharmacology · doi:10.1007/s002130050058 · Cited by 13
Brief psychotherapies for depression: current status
Scott, J. L., & Watkins, E. R. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200401000-00002 · Cited by 13
Cervical vagus nerve stimulation for treatment-resistant depression
Carpenter, L. L., Friehs, G. M., & Price, L. H. (2003) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(02)00121-3 · Cited by 13
Recent Mammalian Gene Duplications: Robust Search for Functionally Divergent Gene Pairs
Hughes, A., & Friedman, R. (2004) · Journal of Molecular Evolution · doi:10.1007/s00239-004-2616-9 · Cited by 13
Nefazodone in primary insomnia: an open pilot study
Wiegand, M. H., Galanakis, P., & Schreiner, R. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.042 · Cited by 13
Gregory, M. L., STECH, N. E., Owens, R. W., & Kalivas, P. W. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.037 · Cited by 13
Ishida, K., MURATA, M., Katagiri, N., Ishikawa, M., Abe, K., Kato, M., Utsunomiya, I., & Taguchi, K. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084764 · Cited by 13
Zetin, M., Potkin, S. G., & Urbanchek, M. G. (1987) · Psychiatric Annals · doi:10.3928/0048-5713-19871001-11 · Cited by 13
Melatonin Agonists for the Treatment of Sleep Disorders and Major Depression
Fitzgerald, L. R., & Reed, J. E. (2004) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(04)39003-2 · Cited by 12
Wang, S. (2004) · Synapse · doi:10.1002/syn.20104 · Cited by 12
Role of noradrenergic fibers of the preoptic area in regulating sleep
Kumar, V. M. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(03)00003-6 · Cited by 12
Pedrazzoli, M., & Benedito, M. A. C. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.06.001 · Cited by 12
Constitutive precoupling to Gi and increased agonist potency in the α2B-adrenoceptor
Ge, H., Scheinin, M., & Kallio, J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01094-5 · Cited by 12
Aizenberg, D., Weizman, A., & Barak, Y. (2003) · Journal of Sex & Marital Therapy · doi:10.1080/00926230390195533 · Cited by 12
Biggs, C. S., & Starr, M. S. (1999) · Synapse · Cited by 12
Comorbid mood disorders and medical illness: a Food and Drug Administration perspective
LAUGHREN, T. P. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00529-8 · Cited by 12
The Brain Epinephrine-α1-Adrenoceptor System in Behavioral Activation and Depression
Stone, E., & Quartermain, D. (2005) · Current Psychiatry Reviews · doi:10.2174/1573400052953565 · Cited by 12
The Neuronal Histaminergic System in Cognition
Passani, M. B., & Blandina, P. (2004) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1568015043477595 · Cited by 12
Norepinephrine transporter splice variants and their interaction with substrates and blockers
Kitayama, S., & Dohi, T. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.057 · Cited by 12
Citalopram Treatment of Fluoxetine-Intolerant Depressed Patients
Calabrese, J. R., Londborg, P. D., Shelton, M. D., & Thase, M. E. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0511 · Cited by 12
Kim, Y.-J. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00054-8 · Cited by 12
The current status of the diagnostic validity and treatment of generalized anxiety disorder
Hunt, C. J. (2002) · Current Opinion in Psychiatry · doi:10.1097/00001504-200203000-00006 · Cited by 12
ECT alters human monoamines in a different manner from that of antidepressant drugs.
Mv, R., Risby, E. D., Hsiao, J., Linnoila, M., & Potter, W. Z. (1988) · PubMed · Cited by 12
Combination therapy for erectile dysfunction: Where we are and what’s in the future
Nehra, A. X., & Kulaksızoğlu, H. (2002) · Current Urology Reports · doi:10.1007/s11934-002-0099-z · Cited by 11
López-Rodríguez, M. L., Benhamú, B., MORCILLO, M. J., Tejada, I., Ávila‐Brande, D., Marco, I., Schiapparelli, L., Frechilla, D., & Río, J. D. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.07.023 · Cited by 11
Serrats, J., Artigas, F., Mengod, G., & Cortés, R. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003924 · Cited by 11
Lehr, E. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1199-7 · Cited by 11
Gobert, A., Cussac, D., Lejeune, F., Newman‐Tancredi, A., Audinot, V., Boutin, J. A., Carr, C., Milligan, G., Rivet, J., Brocco, M., et al. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)80316-9 · Cited by 11
Self-citationFabricio, A. S. C., Tringali, G., Pozzoli, G., & Navarra, P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1984-6 · Cited by 11
Buysse, D. J., Monk, T. H., Kupfer, D. J., Frank, E., & Stapf, D. (1995) · Journal of Psychiatric Research · doi:10.1016/0022-3956(95)00021-v · Cited by 11
Rakovska, A., Kiss, J., Raichev, P., Lazarova, M. I., Kalfin, R. E., & Djambazova, E. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00103-6 · Cited by 11
The role of neuropeptides in sleep modulation
Prospero-Garcia, O. E., & Méndez‐Díaz, M. (2004) · Drug News & Perspectives · doi:10.1358/dnp.2004.17.8.863695 · Cited by 10
EEG profile of litoxetine after single and repeated administration in healthy volunteers.
Patat, A. A., Trocherie, S., Thebault, J. J., Rosenzweig, P., Dubruc, C., Bianchetti, G., Morselli, P. L., & Court, L. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04255.x · Cited by 10
Chang, A. Y., Chan, J. Y. H., & Chan, S. H. H. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703478 · Cited by 10
Asakura, W., Matsumoto, K., Ohta, H., & Watanabe, H. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90459-6 · Cited by 10
Barilà, B., Cupello, A., & Robello, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00257-2 · Cited by 10
Gannon, R. L., & Millan, M. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.012 · Cited by 10
Self-citationBuysse, D. J., Kupfer, D. J., Frank, E., Monk, T. H., & Ritenour, A. (1994) · Depression · doi:10.1002/depr.3050020207 · Cited by 10
Pei, Q., Sprakes, M., Millan, M. J., Rochat, C., & Sharp, T. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.03.002 · Cited by 10
Self-citationThe psychomotor and cognitive effects of litoxetine in young and middle aged volunteers.
Fairweather, D. B., Patat, A. A., Rosenzweig, P., Curson, V. H., Dunmore, C., Dubruc, C., & Hindmarch, I. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05767.x · Cited by 9
Tyrosine depletion does not cause depressive relapse in antidepressant-treated patients
McTavish, S. F. B., Mannie, Z. N., & Cowen, P. J. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1945-0 · Cited by 9
Winter, J. C., Eckler, J. R., Rice, K. C., & Rabin, R. A. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.03.022 · Cited by 9
Sleep–wake effects of meta-chlorophenyl piperazine and mianserin in the behaviorally depressed rat
Mavanji, V., Meti, B. L., & Datta, S. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02553-0 · Cited by 9
Dziedzicka‐Wasylewska, M., Faron‐Górecka, A., Rog�, Z., & Solich, J. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200403000-00008 · Cited by 9
Antidepressants and the placebo response
Berk, M., & Dodd, S. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.697 · Cited by 9
Changes in signaling pathways regulating neuroplasticity induced by neurokinin 1 receptor knockout
Musazzi, L., Pérez, J., Hunt, S. P., Racagni, G., & Popoli, M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03949.x · Cited by 9
Mood disorders in early Parkinson’s disease
Müller, T. H. (2004) · Current Opinion in Psychiatry · doi:10.1097/00001504-200405000-00007 · Cited by 9
Psychiatric and cognitive disorders in Parkinson’s disease
Nilsson, F. M. (2004) · Current Opinion in Psychiatry · doi:10.1097/00001504-200405000-00008 · Cited by 8
Binder, M. D., Hirokawa, N., & Windhorst, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_1112 · Cited by 8
Effect of α2-adrenoceptor blockade on lithium action in the rat brain
x, M. L. C., Carbonell, L., Mármol, F., Giménez, J., & FORN, J. (2003) · Brain Research · doi:10.1016/j.brainres.2003.09.019 · Cited by 8
Tolerance to Anxiolytic- and Antidepressant-Like Effects of a Partial Agonist of GlycineB Receptors
Przegaliński, E., Tatarczynska, E., Kłodzińska, A., & Chojnacka-Wójcik, E. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00214-2 · Cited by 8
Molecular determinants of opioid analgesia: Modulation of presynaptic calcium channels
Beedle, A. M., & Zamponi, G. W. (2001) · Drug Development Research · doi:10.1002/ddr.10026 · Cited by 8
Pharmacogenetics of Selective Serotonin Reuptake Inhibitor Response in Major Depression
Tsai, S., & Hong, C. (2003) · Current Pharmacogenomics · doi:10.2174/1570160033378312 · Cited by 8
Becker, C., André, J., Zeau, B., Rettori, M., Lemaître, B. J., Hamon, M., & Benoliel, J. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.006 · Cited by 8
Genetics and genomics in neuropsychopharmacology: the impact on drug discovery and development
Hurko, O. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00126-2 · Cited by 7
Oestrogens, brain function and neuropsychiatric disorders
Craig, M., Cutter, W. J., Norbury, R., & Murphy, D. (2004) · Current Opinion in Psychiatry · doi:10.1097/00001504-200405000-00010 · Cited by 7
Metabotropic glutamate (mGlu) receptors and nociceptive processing
Salt, T. (2001) · Drug Development Research · doi:10.1002/ddr.10012 · Cited by 7
Electroconvulsive Therapy-Induced Cortisol Release: Changes with Depressive State.
Swartz, C. M., & Chen, J.-J. (1985) · PubMed · Cited by 7
Lithium Carbonate Augmentation of Desipramine in Refractory Depression *
Dallal, A., Fontaine, R., Ontiveros, A., & Elie, R. (1990) · The Canadian Journal of Psychiatry · doi:10.1177/070674379003500709 · Cited by 7
Miralles, A., Ribas, C., Escribá, P. V., & Garcı́a-Sevilla, J. A. (2000) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2000.pto870605.x · Cited by 6
Positive modulators of the AMPA receptor
Grove, S. J. A., Rogers, G. A., & Zhang, M. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.10.1539 · Cited by 6
Developments in the pharmacological treatment of schizophrenia
Kuperberg, G. R., Kerwin, R. W., & Murray, R. M. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1335 · Cited by 6
Combined Pharmacotherapy and Psychological Treatment for Depression: A Systematic Review
Pampallona, S., Bollini, P., Tibaldi, G., Kupelnick, B., & Munizza, C. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.714 · Cited by 5
The cholinergic hypothesis — past and present
Buccafusco, J. J. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7867-8_1 · Cited by 5
The Clinical Neuroscience of Post Stroke Depression
Haroon, E., & Kumar, A. (2004) · Current Neuropharmacology · doi:10.2174/1570159043359567 · Cited by 5
Harvey, M. T., Smith, R. L., May, M. E., Caruso, M., Roberts, C., Patterson, T. G., Valdovinos, M. G., & Kennedy, C. H. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1872-0 · Cited by 5
Anseculin improves passive avoidance learning of aged mice
Knauber, J. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(02)00311-0 · Cited by 5
Adherence with antidepressant medication.
Giannetti, V. J. (2004) · PubMed · Cited by 5
Parker, M. S., Sah, R., Balasubramaniam, A., & Parker, S. L. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.025 · Cited by 3
Cholinergic abnormalities in Alzheimer's disease: are there new targets for drug development?
Fodero, L. R., & Small, D. H. (2002) · Drug Development Research · doi:10.1002/ddr.10089 · Cited by 3
Waeber, B. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.13.2291 · Cited by 2
Impact of gene polymorphisms on depression and its treatment.
Moret, C. (2004) · PubMed · Cited by 2
Antidepressant research in the era of functional genomics: Farewell to the monoamine hypothesis
Yamada, M., Tsunoda, M., Tsukahara, N., et al. (2004) · Biogenic Amines · doi:10.1163/1569391041501898 · Cited by 1
Boothman, L. J., Allers, K. A., Rasmussen, K., et al. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705444 · Cited by 1
Comparison of pramipexole, fluoxetine, and placebo in patients with major depression
(2000) · doi:10.1002/(sici)1520-6394(2000)11:2<58::aid-da2>3.0.co;2-h
Harwood (2001) · doi:10.1002/1099-1166(200102)16:2
S�nchez, M. M., Young, L. J., Plotsky, P. M., & Insel, T. R. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990607)408:3
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.